Paper I
2019 February (2010 Scheme) · 40 marks · 120 min

Question

Leukotriene antagonist

Q190.3 marksShort Answers

Answer

Montelukast — blocks cysteinyl leukotriene (CysLT1) receptors, preventing leukotriene-mediated bronchoconstriction and airway inflammation, making it useful as an add-on therapy in bronchial asthma and allergic rhinitis.

Other Years Asked


Revise MBBS
Preview